AI-Designed Antibodies Achieve Breakthroughs in Drug Development and Protein Design
Researchers from Nobel Laureate David Baker's lab and the University of Washington have used AI to design antibodies from scratch, successfully creating molecules that bind to their targets, potentially revolutionizing the antibody drug industry and enabling faster, more efficient drug development.